C-YTCJCelligenics
secretome, stem cell biology, regenerative biologics
repairingbiologic
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-YTCJ
C-YTCJC-YTCJsecretome, stem cell biology, regenerative biologics
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Celligenics secretome, stem cell biology, regenerative biologics
Celligenics is a Singapore-based regenerative biotech company established in 2016 as an A*STAR spin-off. The company develops secretome-based technologies from stem cell sources for real-world regenerative applications. Its platform is positioned for therapeutics, cosmeceuticals, veterinary health, and longevity-oriented applications, with validation through institutional collaborations, peer-reviewed publication, and internal platform data.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Celligenics — Early mechanism · Lower middle. Derived deterministically from 4 extracted project(s). Most-advanced status: preclinical. Band: early_mechanism. Aging-relevance not LLM-reviewed in this pass.
Source: Deterministic